1. Armstrong, D., 1985, Antifungal prophylaxis in immunocompromised patients, Symposium on in vitro and in vivo evaluation of antifungal agents: Tokyo, June 19–22.
2. Cauwenbergh, G., 1986, Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications, Drug Exp Clin Res, XII(5):419.
3. Cauwenbergh, G., De Doncker, P., Stoops, K., De Dier, A., Goyvaerts, H., and Schuermans, V., 1987, Itraconazole in the treatment of human mycoses: Review of three years of clinical experience., Rev Inf Dis, Vol 9, Suppl 1:S146.
4. Dupont, B., and Drouhet, E., 1987, Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results, Rev Inf Dis, Vol 9, Suppl 1:S71.
5. Echenne, B., Brunei, D., Astruc, J., and Perez, C., 1980, Aspergillose disséminée chez un enfant porteur d’une prothèse aortique. Efficacité du ketoconazole, Med et Mal Infect. 10:263.